Ligand validation:6TK2

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6TK2_LFA_A_303	24%	73%	0.171	0.907	0.31	0.72	-	-	0	0	40%	0.54
6TK2_LFA_A_320	23%	78%	0.154	0.911	0.32	0.56	-	-	0	0	25%	1
6TK2_LFA_A_319	14%	78%	0.225	0.9	0.32	0.56	-	-	0	0	30%	1
6TK2_LFA_A_307	11%	70%	0.237	0.823	0.3	0.85	-	-	1	0	65%	1
6TK2_LFA_A_312	11%	69%	0.203	0.75	0.28	0.9	-	-	0	0	80%	1
6TK2_LFA_A_302	9%	69%	0.209	0.739	0.3	0.86	-	-	1	0	80%	1
6TK2_LFA_A_326	9%	72%	0.194	0.766	0.31	0.77	-	-	1	0	50%	1
6TK2_LFA_A_313	6%	79%	0.23	0.802	0.32	0.55	-	-	1	0	25%	1
6TK2_LFA_A_308	6%	72%	0.264	0.789	0.3	0.78	-	-	0	0	50%	1
6TK2_LFA_A_310	5%	73%	0.263	0.788	0.3	0.73	-	-	0	0	40%	1
6TK2_LFA_A_327	4%	71%	0.327	0.77	0.3	0.82	-	-	0	0	60%	1
6TK2_LFA_A_311	4%	70%	0.246	0.675	0.3	0.84	-	-	0	0	60%	1
6TK2_LFA_A_317	3%	72%	0.297	0.724	0.3	0.76	-	-	0	0	45%	1
6TK2_LFA_A_318	2%	72%	0.251	0.63	0.31	0.77	-	-	3	0	45%	1
6TK2_LFA_A_305	1%	78%	0.319	0.659	0.32	0.56	-	-	0	0	30%	1
6TK2_LFA_A_316	1%	71%	0.387	0.662	0.3	0.82	-	-	2	0	55%	1
6TK2_LFA_A_315	1%	79%	0.302	0.568	0.32	0.54	-	-	0	0	25%	1
6TK2_LFA_A_304	1%	78%	0.31	0.556	0.31	0.57	-	-	0	0	30%	1
6TK2_LFA_A_323	1%	72%	0.295	0.48	0.31	0.77	-	-	2	0	50%	1
6TK2_LFA_A_325	0%	72%	0.491	0.63	0.3	0.77	-	-	1	0	45%	1
6TK2_LFA_A_314	0%	71%	0.451	0.532	0.3	0.8	-	-	0	0	50%	1
6TK2_LFA_A_306	0%	79%	0.444	0.483	0.32	0.54	-	-	1	0	25%	1
6TK2_LFA_A_322	0%	78%	0.453	0.445	0.31	0.57	-	-	0	0	30%	1
6TK2_LFA_A_309	0%	73%	0.414	0.373	0.31	0.73	-	-	0	0	40%	1
6TK2_LFA_A_321	0%	70%	0.629	0.614	0.41	0.73	-	-	0	0	20%	1
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	0	70%	1
4XTL_LFA_A_315	46%	89%	0.079	0.949	0.26	0.38	-	-	1	0	25%	1
4XTN_LFA_J_311	43%	74%	0.092	0.958	0.38	0.61	-	-	1	0	20%	1
6XYT_LFA_C_309	41%	100%	0.165	0.878	0.07	0.05	-	-	0	0	100%	1
6RFC_LFA_A_336	39%	87%	0.105	0.92	0.24	0.46	-	-	0	0	40%	1
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
6SU3_LFA_X_301	65%	96%	0.071	0.945	0.18	0.18	-	-	0	0	60%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	7	0	75%	1
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	1
8R98_LFA_A_401	55%	100%	0.089	0.937	0.09	0.08	-	-	0	0	55%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.